Lucid Diagnostics
LUCD
24 hedge funds and large institutions have $2.24M invested in Lucid Diagnostics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
33% more funds holding
Funds holding: 18 → 24 (+6)
0.12% more ownership
Funds ownership: 4.26% → 4.38% (+0.12%)
14% less capital invested
Capital invested by funds: $2.59M → $2.24M (-$351K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Ayrton Capital
Westport,
Connecticut
|
+$107K |
| 2 |
Jane Street
New York
|
+$25.1K |
| 3 |
LPL Financial
San Diego,
California
|
+$20.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$13K |
| 5 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$59.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$37.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$16.8K |
| 4 |
LM
Luminus Management
Houston,
Texas
|
-$4.75K |
| 5 |
BlackRock
New York
|
-$3.72K |
LUCD Hedge Fund Activity: Q3 2023 in Review
24 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q3 2023, worth a combined $2.24M — down 14% from $2.59M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LUCD positions and 1 closed out — a net gain of 6 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Ayrton Capital, opening a new position worth an estimated $107K. The largest seller was Nantahala Capital Management, cutting an estimated $59.4K.
- 24 institutional investors held Lucid Diagnostics (LUCD) as of Q3 2023, up from 18 in Q2 2023.
- Funds reported $2.24M of Lucid Diagnostics stock for Q3 2023, down 14% quarter-over-quarter.
- 7 funds opened new Lucid Diagnostics positions in Q3 2023 and 1 closed out, a net change of +6 holders.
- The largest Lucid Diagnostics buyer in Q3 2023 was Ayrton Capital, an estimated $107K added.
- The largest Lucid Diagnostics seller in Q3 2023 was Nantahala Capital Management, an estimated $59.4K sold.
Based on aggregated 13F filings for Q3 2023.